Date published: 2026-11-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

CYP1A2 Antibody (F-7): sc-514044

5.0(1)
Write a reviewAsk a question
Datasheets
  • CYP1A2 Antibody (F-7) is a mouse monoclonal IgG1 κ provided at 200 µg/ml
  • specific for an epitope mapping between amino acids 431-458 within an internal region of CYP1A2 of mouse origin
  • recommended for detection of CYP1A2 of mouse and rat origin by WB, IP, IF and ELISA
  • m-IgG Fc BP-HRP, m-IgG1 BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for CYP1A2 Antibody (F-7) for WB applications. These reagents are now offered in bundles with CYP1A2 Antibody (F-7) (see ordering information below).
    Gene Editing Promo Banner

    QUICK LINKS

    SEE ALSO...

    CYP1A2 Antibody (F-7) is a mouse monoclonal IgG1 antibody that detects CYP1A2 in mouse and rat samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). CYP1A2, also known as Cytochrome P450 1A2, is a crucial heme-thiolate monooxygenase enzyme that plays a significant role in the NADPH-dependent electron transport pathway within liver microsomes. This enzyme is essential for the oxidation of various substrates, including fatty acids, steroids, and xenobiotics, which are vital for drug metabolism and detoxification processes in the liver. Notably, CYP1A2 is involved in the metabolism of several important pharmaceuticals, such as imipramine, propranol, and clozapine, highlighting CYP1A2′s relevance in pharmacokinetics and personalized medicine. The localization of CYP1A2 to the endoplasmic reticulum membrane is critical, as this positioning facilitates CYP1A2′s interaction with various substrates and electron transport proteins, thereby enhancing metabolic efficiency. Furthermore, CYP1A2 is subject to induction by compounds like 3-methylcholanthrene and insulin, while CYP1A2′s activity can be inhibited by several fluoroquinolone antibiotics, caffeine, fluvoxamine, and cimetidine, making CYP1A2 a key player in drug-drug interactions. Importantly, CYP1A2′s involvement in estrogen metabolism has been linked to a reduced risk of breast cancer, underscoring CYP1A2′s potential implications in cancer research and therapeutic strategies.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    Contains Mercury: All HRP conjugates (including bundle forms) contain thiomersal, a mercury compound. Do not dispose in trash. Dispose as hazardous chemical waste according to local, state and federal regulations.

    Download thiomersal SDS

    CYP1A2 Antibody (F-7) References:

    1. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.  |  Han, XM., et al. 2002. Br J Clin Pharmacol. 54: 540-3. PMID: 12445035
    2. Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo.  |  Karjalainen, MJ., et al. 2008. Eur J Clin Pharmacol. 64: 511-9. PMID: 18197403
    3. Conserved genomic structure of the Cyp1a1 and Cyp1a2 loci and their dioxin responsive elements cluster.  |  Nukaya, M. and Bradfield, CA. 2009. Biochem Pharmacol. 77: 654-9. PMID: 19026991
    4. Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.  |  Dobrinas, M., et al. 2013. Pharmacogenet Genomics. 23: 286-92. PMID: 23492909
    5. Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.  |  Perera, V., et al. 2013. Expert Opin Drug Metab Toxicol. 9: 1115-37. PMID: 23641727
    6. CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations.  |  Czerwensky, F., et al. 2015. Ther Drug Monit. 37: 152-60. PMID: 25090458
    7. Effect of Caffeine on Endurance Performance in Athletes May Depend on HTR2A and CYP1A2 Genotypes.  |  Guest, NS., et al. 2022. J Strength Cond Res. 36: 2486-2492. PMID: 32569126
    8. Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro.  |  Yim, SK., et al. 2020. Mar Drugs. 18: PMID: 33260381
    9. The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes.  |  Albassam, AA., et al. 2021. Pharmazie. 76: 155-158. PMID: 33849700
    10. Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers & Non-smokers in Different Doses.  |  Bilal, R., et al. 2022. Pak J Med Sci. 38: 589-594. PMID: 35480532

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    CYP1A2 Antibody (F-7)

    sc-514044
    200 µg/ml
    $322.00

    CYP1A2 Antibody (F-7): m-IgG Fc BP-HRP Bundle

    sc-538574
    200 µg Ab; 10 µg BP
    $361.00

    CYP1A2 Antibody (F-7): m-IgGκ BP-HRP Bundle

    sc-536212
    200 µg Ab; 40 µg BP
    $361.00

    CYP1A2 Antibody (F-7): m-IgG1 BP-HRP Bundle

    sc-545775
    200 µg Ab; 20 µg BP
    $361.00

    CYP1A2 (F-7) Neutralizing Peptide

    sc-514044 P
    100 µg/0.5 ml
    $69.00

    What application is the blocking peptide sc-514044 P appropriate for?

    Asked by: DefinitelyNotMatt
    Thank you for your question. The blocking peptide is intended for use as a negative control, by pre-adsorbing the mouse monoclonal antibody against the antigen. For full protocol details, please contact our Technical Services Department or view our online protocol here: https://www.scbt.com/scbt/resources/protocols/peptide-neutralization
    Answered by: Technical Support
    Date published: 2017-02-27
    • y_2026, m_11, d_18, h_6CST
    • bvseo_bulk, prod_bvqa, vn_bulk_3.0.50
    • cp_1, bvpage1
    • co_hasquestionsanswers, tq_1
    • loc_en_US, sid_514044, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
    • clientName_scbt
    • bvseo_sdk, java_sdk, bvseo-4.0.0
    • CLOUD, getContent, 99ms
    • QUESTIONS, PRODUCT
    Rated 5 out of 5 by ET from Strong bands observed with both mouse liverStrong bands observed with both mouse liver tissue extract and transfected cell lysates -SCBT QC
    Date published: 2013-04-22
    • y_2026, m_11, d_17, h_7
    • bvseo_bulk, prod_bvrr, vn_bulk_3.0.50
    • cp_1, bvpage1
    • co_hasreviews, tv_0, tr_1
    • loc_en_US, sid_514044, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
    • clientName_scbt
    • bvseo_sdk, java_sdk, bvseo-4.0.0
    • CLOUD, getReviews, 20ms
    • REVIEWS, PRODUCT
    CYP1A2 Antibody (F-7) is rated 5.0 out of 5 by 1.
    • y_2026, m_11, d_17, h_7
    • bvseo_bulk, prod_bvrr, vn_bulk_3.0.50
    • cp_1, bvpage1
    • co_hasreviews, tv_0, tr_1
    • loc_en_US, sid_514044, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
    • clientName_scbt
    • bvseo_sdk, java_sdk, bvseo-4.0.0
    • CLOUD, getAggregateRating, 99ms
    • REVIEWS, PRODUCT